Doctors Drug Trials Trials 
World of DTC Marketing
AUGUST 9, 2021
The best approach is to use social media to connect HCPs to clincial information and drug trials. Doximity was flagged for having anti-vaccine information. HCPs don’t necessarily want pharma trying to sell products via social media.
pharmaphorum
MAY 14, 2021
But Reuters reported that the doctor identified as its principal clinical trial investigator has said he is not in charge of the trial. Reuters quoted Kintor’s chief financial officer Lucy Lu, who said that Kayali was one of its trial investigators.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
JANUARY 16, 2023
A Florida doctor has been sent to prison after submitting a false affidavit claiming she had screened children in a clinical study looking at the effectiveness of drugs given to children with asthma when she had not.
pharmaphorum
DECEMBER 1, 2022
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in clinical trials. A 2018 NIH survey found that patients felt clinical trial participation to be inconvenient and burdensome, and nearly half (49.0%) said it disrupted their daily routine.
XTalks
FEBRUARY 25, 2022
There has been increasing awareness around the need for improving inclusion and diversity in clinical trials. Despite these statistics, in the US, Black people only constitute five percent of all clinical trial participants. The overwhelming majority of trial participants nationwide are white. Medical Mistrust.
pharmaphorum
AUGUST 25, 2022
That was until my doctors stunned me with the news that I had cirrhosis caused by non-alcoholic steatohepatitis, or NASH, a severe form of fatty liver disease that often has few or no symptoms until very late stages. The company is also enrolling patients for its global Phase 2b/3 trial, potentially one the largest trials of its kind.
Pharmaceutical Technology
SEPTEMBER 7, 2022
Before drugs are authorised, evidence of their safety and efficacy is limited to results from clinical trials, so it is essential that pharmacovigilance continues after a therapy has been approved. After AEs are recorded, they must be translated and put back out to doctors and scientists for processing.
Expert insights. Personalized for you.
294 
Let's personalize your content